Skip to content

OrthoPediatrics KIDS EBITDA margin

EBITDA margin at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
34.4%+2.7pp
Stryker logo
StrykerSYK
24.6%+4.7pp
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
-3%-1.1pp
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
27.2%-3.0pp
Medtronic logo
MedtronicMDT
25.9%-0.4pp
Alphatec Holdings logo
Alphatec HoldingsATEC
2.1%+1.1pp

Other financials

Income statement

See full
Revenue$59.4M+13.3%
Gross profit$43.4M+13.4%
Operating income-$8.3M+24.1%
Net income-$10.7M-0.3%
EPS (diluted)-$0.45+2.2%

Balance sheet

See full
Cash & equivalents$14.2M-59.8%
Total debt$5.4M+271%
Total equity$338.7M-2.4%
Total assets$502.2M+6.8%

Cash flow

See full
Operating cash flow-$3.3M+20.9%
CapEx$1.8M-58.4%
Free cash flow-$5.0M+39.8%

Valuation

See full
Market cap$503.94M+0.3%
Enterprise value$495.11M+5.7%
P/S2.1×-0.3×

Profitability

See full
Gross margin73.1%+0.3pp
Operating margin-15%-1.6pp
Net margin-16.3%-2.1pp
FCF margin-12.9%-4.3pp

Returns & leverage

See full
Return on equity-11.6%+0.2pp
Debt / equity0.0×
Current ratio5.2×-1.0×

Where this comes from

Calculated from OrthoPediatrics’s reported figures.

Based on trailing twelve months.

The official record: OrthoPediatrics’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about OrthoPediatrics's ebitda margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OrthoPediatrics's EBITDA margin?
OrthoPediatrics (KIDS) reported EBITDA margin of -6.1% in Q1 2026.
How has OrthoPediatrics's EBITDA margin changed year-over-year?
OrthoPediatrics's EBITDA margin increased by 24.7% year-over-year, from -8.1% to -6.1%.
What is the long-term trend for OrthoPediatrics's EBITDA margin?
Over 5 years (2020 to 2025), OrthoPediatrics's EBITDA margin has grown at a -21.9% compound annual growth rate (CAGR), from -26.4% to -7.7%.
What does EBITDA margin mean?
EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.